Validated capability from Product Development to GMP-approved Commercial Manufacturing
At Adare Pharma Solutions, our goal is to provide peace of mind by leveraging decades of expertise gained from working in the contract drug development and manufacturing (CDMO) space. Our three facilities are cGMP certified, FDA inspected and large enough to accommodate commercial-scale projects.
Adare creates a seamless transition at each stage of drug product development and manufacturing. In addition to our highly experienced team, we offer a number of drug development technologies that facilitate the commercialization of safe pharmaceutical products.
We deliver a comprehensive suite of services that are built to guide you from proof of concept to commercialization. Our integrated service teams are equipped with experienced, trusted leaders from the top pharmaceutical companies. From drug development to scale-up through packaging, we are ready to support you with efficiency in every part of your drug product development.
Our Product Development team includes specialists in technology innovation, formulation, analytical method development and technical services. We have helped dozens of customers like you optimize processes, develop formulations, manage their supply chains, and launch their products.
- Formulation development
- Support including physical characterization
- Analytical Method Development & Validation
- IMPD Manufacture and QP release
- Tech Transfer
- ICH stability programs at all conditions
- Efficient product development pathways for NCEs, ANDA, 505(b)(2), IND/NDAs, and novel delivery systems
- Preclinical to clinical to commercial capability
- IVIVC-based modified release dosage form development
Speak With An Expert
Srinivasan Shanmugam, Ph.D
Senior Director, Pharmaceutical Sciences, Business Support, and New Technologies
Dr. Srinivasan Shanmugam is involved in the development and expansion of Adare’s pharmaceutical technology portfolio and supports product development, co-development, and tech transfer opportunities. Dr. Shanmugam has a Ph.D. M.S., and a B.S. in Pharmacy. Dr. Shanmugam has more than 20 years of experience in designing and development of conventional, NDDS/alternate, advanced/modified drug delivery systems, and pharmaceutical platform technologies for oral and other routes of administration. His expertise includes enabling technologies for challenging drugs and developing platform technologies. Additionally, his expertise includes patient-centric solutions focusing on pediatric and geriatric populations to achieve dose convenience, flexibility, and precision. Dr. Shanmugam has published numerous research articles, holds multiple patents, and is a reviewer/editorial member of various prestigious journals. Shanmugam’s recent work focuses on product development solutions for special patient populations like pediatric and geriatric populations.